Author: Brittney Wheeler

Washington University School of Medicine is one of four institutions to receive a National Institutes of Health (NIH) grant to study how to improve emergency care for adults with dementia. For the project, experts in emergency medicine, geriatrics and dementia will identify and address gaps in emergency care.

Although viruses such as herpes simplex can infect the eye’s cornea and Zika virus has been found in corneal tissue and tears, new School of Medicine research suggests the cornea can resist infection from the novel coronavirus.

By studying animals choosing between drink options, School of Medicine researchers have found that the activity of certain neurons in the brain leads directly to the choice of one option over another. The findings could lead to better understanding of how decision-making goes wrong in conditions such as addiction and depression.

Washington University in St. Louis’ Emergency Management Department has been awarded full accreditation by the Emergency Management Accreditation Program, an accomplishment only eight universities in the country have achieved.

People with Down syndrome nearly always develop signs of Alzheimer’s as they age. School of Medicine researchers are taking part in a multisite study to understand how Alzheimer’s develops in this population, with a long-term goal of finding ways to prevent or treat the disease.

An international team of researchers led by scientists at the School of Medicine has identified two regions in our DNA — one newly identified and a second that replicates a past finding — that appear to contribute to one’s risk of becoming dependent on marijuana.

Pharmaceutical maker Eli Lilly and Company has purchased Disarm Therapeutics, a startup biotechnology firm founded by researchers at Washington University School of Medicine to speed the development of treatments for multiple neurodegenerative conditions.

A new, international phase 3 clinical trial led by the Washington University School of Medicine and funded by the National Institutes of Health (NIH), will investigate the potential of three drugs to tame a dangerous inflammatory response seen in some COVID-19 patients.

School of Medicine researchers have received an $8.5 million grant to study the role of gut viruses in inflammatory bowel disease. Tools developed in the course of the project could accelerate research into other roles of the virome in health and disease.

A new grant for research at the School of Medicine focuses on brain scans and other markers of Alzheimer’s. The aim is to establish whether early markers of disease in white populations also apply to African Americans.